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http://dx.doi.org/10.1016/j.jds.2013.0Abstract Background/purpose: We studied the correlation between clinical covariates and
blood loss under hypotensive anesthesia, in patients undergoing a bilateral vertical ramus os-
teotomy (BVRO).
Materials and methods: BVROs were performed on 37 patients with mandibular prognathism.
The preoperative and postoperative values of blood constituents were examined and analyzed.
Correlations among blood loss, sex, age, operative time, and reduced values of blood constit-
uents were statistically assessed.
Results: The average operative time was 255.5  42.56 minutes, and blood loss was
105.9  66.83 mL. No patient required a blood transfusion in this study. There were no signif-
icant correlations between blood loss and related factors (sex, operative time, and reductions
in blood constituents). Comparing sexes, blood loss and reductions in blood constituents exhib-
ited non-significant differences. However, male patients had significantly larger values for pre-
surgical and postsurgical blood constituents than female patients.
Conclusion: In our study, blood loss was acceptable in patients who underwent a BVRO, and
thus, no preoperative autologous blood donation was necessary.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published
by Elsevier Taiwan LLC. All rights reserved.of Family Dentistry, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, San Ming District,
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250 H.-S. Chen et alIntroductionTable 1 Summary of all patients (n Z 37).
Sex (n)* Male Z 24;
Female Z 13
Age (y) Mean Z 24;
range, 18e35
Variables Mean SD
Blood loss (ml) 105.9
(range Z
50e320)
66.83
Operative time (minutes) 255.5
(range Z
165e385)
42.65
Presurgical blood ingredients
Red blood cells (106/mL) 4.7 0.72
Hemoglobin (g/dL) 13.8 1.55
Hematocrit (%) 40.8 4.25
Postsurgical blood ingredients
Red blood cells (106/mL) 4.1 0.61
Hemoglobin (g/dL) 11.9 1.53
Hematocrit (%) 35.1 4.11Orthognathic surgery is performed extensively throughout
the world, due to its ability to improve tooth and jaw de-
formities. Orthognathic surgery requires a great deal of
skill; the surgical field is often limited when performing
procedures in the mouth. A bilateral vertical ramus
osteotomy (BVRO) is a popular method of treating
mandibular prognathism. Although accuracy in the surgical
procedures is crucial, clinicians must also pay close atten-
tion to other variables, such as the duration of surgery and
blood loss. More accurate estimates of the predicted sur-
gical duration and volume of blood loss could enable sur-
geons and anesthetists to improve management during the
operation. The possibility of blood loss and the need for
intraoperative transfusions, raise concerns among surgical
staff and patients alike. In addition, many patients may
also worry about transfusion-related risk factors.
In Taiwan, hypotensive anesthesia has been used in
orthognathic surgery, to reduce blood loss. The volume of
bleeding among various orthognathic surgical procedures
has not been estimated and relative data on blood loss and
blood variables are scarce. In fact, there is not yet a
consensus on the necessity for a blood transfusion during
orthognathic surgery. Many approaches1e4 have been
adopted to prevent blood loss during operations and to
reduce the need for autologous transfusions. Among these
approaches, hypotensive anesthesia is well established as
an effective technique, and is particularly applied for
maxillofacial surgery. The aim of the present study was to
determine correlations between blood loss and related
factors during a BVRO.
Materials and methods
Thirty-seven patients participated in the study, all of whom
had undergone a BVRO to treat mandibular prognathism at
the Oral and Maxillofacial Department of Kaohsiung Medical
University Hospital. After nasotracheal intubation, all pa-
tients inhaled the anesthetic agent, sevoflurane. The mean
arterial pressure (MAP) of patients was maintained at
approximately 60 mmHg. Both incision lines were injected
with 2% lidocaine containing 1:105 adrenalin. Intraoperative
blood loss was quantified by measuring the amount in the
collecting container and weighing the gauze. The BVRO
technique was performed by a single surgeon in a one-jaw
procedure, and postsurgically, an interocclusal resin splint
and intermaxillary fixation were retained for at least 6
weeks. All operations were performed by the same surgeon
with the same anesthesia protocols.
We retrospectively reviewedpatients’ charts, and related
data were recorded, such as patient characteristics, opera-
tive time, intraoperative blood loss, presurgical and post-
surgical changes in blood constituents [the red blood cell
(RBC) count, hemoglobin (Hb), and hematocrit (Hct)].
Changes in blood constituents due to surgerywere calculated
and analyzed by a paired t test. Pearson’s correlation coef-
ficient was used to detect correlations between blood loss
and various parameters. A P value of  0.05 was considered
significant. All data were analyzed using JMP statistical
software (version 7.0; SAS Institute, Cary, NC, USA).Results
There were 24 female and 13 male patients. The mean age
was 24 years (range Z 18e35 years). No patient had a
coagulation deficiency or was undergoing anticoagulation
therapy. None of the patients had received a blood trans-
fusion during hospitalization. Table 1 shows a mean oper-
ative time of 255.5  42.56 minutes and a mean blood loss
of 105.9  66.83 mL. The maximum blood loss was 320 mL,
which resulted in a 1.7 g/dL decrease in the Hb value, and a
5.6% decrease in Hct. The minimum blood loss was 50 mL,
which resulted in a 1 g/dL decrease in the Hb value, and a
3.2% decrease in Hct. Table 2 shows comparisons of pa-
rameters between female and male patients. Male patients
had a longer operative time (42.5 minutes) and greater
blood loss (19.5 mL) than female patients. Table 3 shows
reductions in values of the various blood constituents.
Postsurgical reductions in blood constituents were signifi-
cant in both female and male patients.
As to correlations between blood loss and various fac-
tors, there were no significant differences in operative time
or reductions in blood constituents between female and
male patients, as shown in Table 4. Comparisons of corre-
lations between female and male patients are presented in
Table 5. Age, blood loss, and reductions in blood constitu-
ents, did not significantly differ between female and male
patients. However, values of presurgical and postsurgical
blood constituents of male patients were significantly
higher than those of female patients.
Discussion
Because the maxillofacial region has an abundant blood
supply, oral and maxillofacial surgeons must consider blood
loss during orthognathic surgery. These surgical procedures
require highly specialized techniques, and in some cases,
Table 2 Comparisons of female and male patients.
Sex (n)* Female Male
Variables Mean SD Mean SD
Age (y) 24.5 4.06 23.1 4.89
Blood loss (ml) 99.0 72.85 118.5 54.41
Operative time (min) 240.6 36.66 283.1 40.18
Presurgical blood ingredients
Red blood cells (106/mL) 4.5 0.60 5.2 0.73
Hemoglobin (g/dL) 13.0 1.30 15.2 0.82
Hematocrit (%) 38.6 3.44 44.8 2.21
Postsurgical blood ingredients
Red blood cells (106/mL) 3.9 0.50 4.4 0.66
Hemoglobin (g/dL) 11.3 1.42 13.1 0.92
Hematocrit (%) 33.4 3.69 38.4 2.68
Table 4 Correlations between blood loss and various
parameters.
Variable Correlation P
Total patients
Reduced blood ingredients
Operative time 0.19 0.2704
Red blood cells (106/mL) 0.23 0.1668
Hemoglobin (g/dL) 0.23 0.1645
Hematocrit (%) 0.25 0.1287
Female patients
Reduced blood ingredients
Operative time 0.03 0.8865
Red blood cells (106/mL) 0.21 0.3363
Hemoglobin (g/dL) 0.27 0.2080
Hematocrit (%) 0.27 0.2044
Male patients
Reduced blood ingredients
Operative time 0.39 0.1886
Red blood cells (106/mL) 0.22 0.4649
Hemoglobin (g/dL) 0.12 0.6944
Hematocrit (%) 0.17 0.5820
Pearson’s correlation coefficient: significant *P < 0.05; very
significant **P < 0.01; highly significant ***P < 0.001.
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blood loss from bone and soft tissues. Therefore, re-
quirements of intraoperative transfusions are a concern to
both surgeons and patients. Autologous transfusions are
widely used, due to concerns of infection during blood
transfusion, particularly with respect to acquired immune
deficiency syndrome (AIDS). Marciani and Dickson5 indi-
cated that such risks are low with autologous transfusions.
For patients of orthognathic surgery, autologous trans-
fusions are very beneficial compared to allogeneic blood
transfusions.
Neuwirth et al6 indicated that in orthognathic surgery,
patients who receive an autologous transfusion regain
normal activity more quickly than patients who do not
receive a transfusion. If an autologous transfusion is to be
applied, it must be completed shortly before surgery, to
enable the volume of plasma to return to normal. Marciani
and Dickson5 also suggested a 3-day interval between an
autologous blood donation and surgery, and the final
donation must be performed no less than 72 hours prior to
surgery. In addition, patients should be informed of the
possibility of a transfusion in certain cases of orthognathicTable 3 Reductions in values of various blood
constituents.
Variable Mean SD P
Reduced blood ingredients
Total patients
Red blood cells (106/mL) 0.7 0.26 ***
Hemoglobin (g/dl) 1.9 0.72 ***
Hematocrit (%) 5.7 2.08 ***
Female patients
Red blood cells (106/mL) 0.6 0.26 ***
Hemoglobin (g/dL) 1.7 0.63 ***
Hematocrit (%) 5.3 1.81 ***
Male patients
Red blood cells (106/mL) 0.8 0.25 ***
Hemoglobin (g/dL) 2.1 0.85 ***
Hematocrit (%) 6.4 2.39 ***
Significant *P < 0.05; very significant **P < 0.01; highly signifi-
cant *** P < 0.001.surgery and the risks involved with blood transfusions.
However, Marciani and Dickson5 discovered negative con-
sequences of autologous blood donations: the procedure is
time consuming, collected blood may come from a patient
with poor health, microemboli and coagulopathy conditions
are possible, hypovolemia may possibly develop, and
human error can occur during the donation procedure.
Discarding autologous blood might even cause Hct values to
decline. In addition, a number of patients might require a
transfusion, due to a decrease in the preoperative Hct.
Moreover, the impact of hypervolemic hemodilution from a
crystalloid injection may lead to a reduction in theTable 5 Correlations between female and male patients.
Variable P
Age 0.4079 d
Blood loss 0.3207 d
Operative time (min) 0.0040 *
Presurgical blood ingredients
Red blood cells (106/mL) 0.0089 **
Hemoglobin (g/dL) <0.0001 ***
Hematocrit (%) <0.0001 ***
Postsurgical blood ingredients
Red blood cells (106/mL) 0.0147 *
Hemoglobin (g/dl) <0.0001 ***
Hematocrit (%) <0.0001 ***
Reduced blood ingredients
Red blood cells (106/mL) 0.2046 d
Hemoglobin (g/dl) 0.2165 d
Hematocrit (%) 0.1311 d
d Z not significant; * P < 0.05; ** P < 0.01; *** P < 0.01.
252 H.-S. Chen et alimmediate postoperative Hct, even if this occurs under a
tolerable total RBC mass.
Sollevi7 stated that the risk of transmitting disease
through blood products emphasizes the importance of sur-
gical techniques that reduce blood loss (e.g., hypotensive
anesthesia). The necessity for a transfusion can be reduced
by applying acute normovolemic hemodilution, to control
hypotensive anesthesia, using a cell energy-saving device,
pre-precipitating autologous blood, and supplying human
recombinant erythropoietin. Controlled hypotensive anes-
thesia must be performed by an experienced anesthesiol-
ogist familiar with its contraindications, and the technique
requires sufficient monitoring equipment to prevent blood
loss from tissues.
Many studies1,2,8 confirmed that hypotensive anesthesia
may provide a clearer surgical field and reduce surgery times,
which in turn prevents the need for a transfusion. Schaberg
et al9 indicated that hypotensive anesthesia may result in a
decrease in systemic blood loss of 40w50%. Hypotensive
anesthesia is often induced by systemic vasodilators and
ganglionic blocking agents and by changing the position of the
patient to alter regional tissue perfusion. During the surgical
procedure, close monitoring of anesthesia and communica-
tion between the doctor/anesthetist increases the safety of
the anesthesia, shortens the surgical time, and reduces
intraoperative blood loss and the possible need for a trans-
fusion. Controlled induction and the maintenance of intra-
operative hypotensive anesthesia have become critical parts
of operations in the maxillofacial region.
Based on the requirements of the surgical field, theMAPof
our patients was controlled to near 60 mmHg, to reduce
blood loss. Current data2,10 indicate that an MAP of
50w65 mmHg is relatively safe for young, healthy patients.
Nonetheless, the blood flow in organs is normally controlled,
and controlled hypotension is unlikely to cause damage. In
orthognathic surgery, the criteria as to whether or not to
performan intraoperative transfusion differ among teams. In
the past 10 years, the use of non-transfusion approaches has
increased. The conventional transfusion guideline of a he-
moglobin limit of 10 g/L is no longer a commonly used stan-
dard, and surgeries are now successfully performed with a
hemoglobin limit of 8 g/L. For mandibular ramus osteoto-
mies, Yu et al11 reported that the mean blood loss was
approximately 280 mL, and the mean operative time was 2
hours. Moenning et al12 indicated that in 506 orthognathic
surgeries, only four patients actually required a transfusion,
and the average blood loss was 975 mL. Moenning et al12 re-
ported 171 patients who underwent a bilateral sagittal split
osteotomy (SSRO), and their average blood loss was 176.6mL
(range Z 50e750 mL), without a blood transfusion. In
comparison to Moenning’s study, our patients revealed a
lower blood loss, with an average loss of 105.9 mL
(range Z 50e320 mL). Many researchers12e14 also discov-
ered that transfusions are unnecessary in single-jaw surgery.In conclusion, no significant factor was associated with
blood loss among patients undergoing a BVRO. Further-
more, hypotensive anesthesia can reduce blood loss, which
in turn minimizes transfusion-related risks, enhances the
surgical field, and shortens the surgical time.Conflicts of interest
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